Allegheny Health Network Amyloidosis Program | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Allegheny Health Network Amyloidosis Program

Allegheny Health Network Amyloidosis Program

30 Isabella St.
Pittsburgh, Pennsylvania, United States
Phone   Web  

The new Amyloidosis Program at Allegheny Health Network (AHN) will draw upon the amyloid expertise of providers across multiple sub-specialties to develop individualized treatment plans for patients. With the help of increasingly sophisticated diagnostic testing and enhanced clinical awareness about the disease, this historically elusive condition can now be diagnosed in a timelier and more accurate fashion.

Physicians at Allegheny Health Network believe a novel multidisciplinary approach to patient care, together with emerging diagnostic and therapeutic advances can help to transform a rare disease called amyloidosis from a terminal illness into a manageable one.

AHN has built a team that brings together not only cardiologists specializing in heart failure and cardiac imaging, but also hematologists, nephrologists, neurologists, pathologists, and palliative care providers, plus nurses, pharmacists, genetic counselors, social workers, and nutritionists. They have developed pathways and protocols to enable a faster diagnosis that allows treatment to start as quickly as possible.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close